BioNTech is losing its chief strategy officer, with Ryan Richardson set to leave the company at the end of September to ...

Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.

An expert panel of the EU drug regulator, the European Medicines Agency (EMA) on Friday recommended marketing authorizations ...

BioNTech SE's turn toward oncology treatments has the potential to tap multi-billion-dollar markets in the future. Find out ...

EMA committee recommends marketing approval of Pfizer & BioNTech’s LP.8.1-adapted Covid-19 vaccine: New York Saturday, July 26, 2025, 10:00 Hrs [IST] Pfizer Inc. and BioNTech SE ...

BioNTech and Pfizer raised this year's production target for their Covid-19 vaccine to as many as 2.5 billion doses, with the German biotech's chief executive predicting a version of the shot ...

BioNTech has generated around 40.5 billion euros ($43.9 billion) since starting its COVID-19 vaccine rollout with partner Pfizer in late 2020, so any amount owed could be quite substantial for the ...

In adults 18 years of age and older, Comirnaty Omicron XBB.1.5, Comirnaty JN.1 and Comirnaty KP.2 may be administered concomitantly with a pneumococcal conjugated vaccine (PCV). an unadjuvanted ...

A global biotech is axing more of its Greater Washington workforce, eliminating nearly 100 positions across multiple waves of ...

BioNTech reported surprisingly strong sales of its COVID-19 vaccine in the third quarter, which reached €1.24 billion ($1.35 billion) and more than doubled the consensus estimate of $652 million.

MAINZ, Germany, May 27, 2025 -- BioNTech SE (Nasdaq: BNTX, "BioNTech” or "the Company”) will present clinical trial data from select pipeline candidates across the Company's diversified oncology ...

Pfizer-BioNTech's COVID-19 vaccine, which was once hailed as a lifesaver, has been found to have subtle but serious side ...